BiomX Ltd.

www.biomx.com

Formerly MBcure

Public Company

(NYSE: PHGE)

Graduated from: FutuRx

TAGS

Artificial Intelligence, Biotechnology, Computational Biology, Deep Tech, Synthetic Biology, Therapeutics

General Data

Sector	Life Sciences
Sub-Sector	Pharmaceuticals

TECHNOLOGY

BiomX is developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

PIPE

Mar. 18, 2024

Revenue Growth

$50m

N/A

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated: Mar 19, 2024